Astaldi S.p.A. informs that it has signed the closing on the sale of its 59.4% stake in Veneta Sanitaria Finanza di Progetto S.p.A., the concession holder for «Ospedale dell’Angelo» in Venice-Mestre, Italy (also known as the New Hospital in Mestre). The transaction amount is in line with the amount indicated in the concession asset disposal program described in the 2018-2022 Strategy Plan of the Group and with the book value.
Indeed, Astaldi S.p.A. and its investee Astaldi Concessioni S.p.A. transferred respectively 53.9% and 5.5% of the share capital of Veneta Sanitaria Finanza di Progetto to Core Infrastructure II S. à r. l., an institutional infrastructure fund controlled by Mirova S.A., a wholly owned subsidiary of OSTRUM Asset Management Group (formerly Natixis Asset Management), dedicated to responsible investments. Further to the transaction, Core Infrastructure II acquires 59.4% of the share capital of the concession holder in which Astaldi and Astaldi Concessioni continue to hold a 0.5% interest each, thus guaranteeing continuity both in the development of infrastructure operation and in the relationship with the granting local Health Authority, U.L.S.S. 3 Serenissima.
The transaction is aimed at allowing a new partner of leading international standing to become a shareholder of the concession, hence opening the door to an institutional investor endowed by the necessary general requisites and the financial solidity for the future operation of the hospital.
The New Hospital in Mestre, a centre of healthcare excellence in Italy and one of the most state-of-the-art hospital facilities in Europe with 680 beds, occupies a total surface area of 260,000 sqm and has been operational since April 2008.